Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, New York 10065, USA.
J Urol. 2012 Aug;188(2):398-404. doi: 10.1016/j.juro.2012.04.009. Epub 2012 Jun 13.
We investigated the clinical and prognostic impact of variant histologies on upper tract urothelial carcinoma outcomes after radical nephroureterectomy.
Data on 1,648 patients with upper tract urothelial carcinoma treated with radical nephroureterectomy without preoperative chemotherapy or radiotherapy were reviewed for histological differentiation and variants. We analyzed differences between pure upper tract urothelial carcinoma and upper tract urothelial carcinoma with variant histology, and differences in the histological variants using different stratifications.
A total of 398 patients (24.2%) had histological upper tract urothelial carcinoma variants. The most common variants were squamous cell and glandular differentiation in 9.9% and 4.4% of cases, respectively. Histological variants were associated with advanced tumor stage, tumor multifocality, sessile tumor architecture, tumor necrosis, lymphovascular invasion and lymph node metastasis compared to pure upper tract urothelial carcinoma (p ≤0.031). On univariable analysis variant histology was associated with disease recurrence (p = 0.002) and cancer specific mortality (p = 0.003). In 174 patients treated with adjuvant chemotherapy there was no difference in disease recurrence or survival between variant histology and pure upper tract urothelial carcinoma (p = 0.42 and 0.59, respectively). On multivariable analysis adjusted for the effects of standard clinicopathological characteristics variant histology was not associated with either end point.
Almost 25% of patients with upper tract urothelial carcinoma treated with radical nephroureterectomy harbored histological variants. Variant histology was associated with features of biologically aggressive upper tract urothelial carcinoma. While variant histology is associated with worse outcomes on univariable analysis but this effect did not remain significant on multivariable analysis.
我们研究了在上尿路尿路上皮癌根治性肾输尿管切除术后,变异组织学对患者临床和预后的影响。
对 1648 例未经术前化疗或放疗行根治性肾输尿管切除术治疗的上尿路尿路上皮癌患者的组织学分化和变异情况进行了回顾性分析。我们分析了单纯上尿路尿路上皮癌与上尿路尿路上皮癌伴变异组织学之间的差异,并对不同分层的组织学变异进行了分析。
共有 398 例(24.2%)患者存在上尿路尿路上皮癌的组织学变异。最常见的变异分别为鳞状细胞分化(9.9%)和腺分化(4.4%)。与单纯上尿路尿路上皮癌相比,组织学变异与肿瘤晚期、肿瘤多灶性、息肉状肿瘤结构、肿瘤坏死、血管淋巴管浸润和淋巴结转移相关(p≤0.031)。单变量分析显示,变异组织学与疾病复发(p=0.002)和癌症特异性死亡(p=0.003)相关。在 174 例接受辅助化疗的患者中,变异组织学与单纯上尿路尿路上皮癌的疾病复发或生存无差异(p=0.42 和 0.59)。多变量分析调整了标准临床病理特征的影响后,变异组织学与这两个终点均无相关性。
在上尿路尿路上皮癌根治性肾输尿管切除术后,近 25%的患者存在组织学变异。变异组织学与具有生物学侵袭性的上尿路尿路上皮癌特征相关。虽然变异组织学与单变量分析中的不良结局相关,但多变量分析中这种影响并不显著。